Atea Pharmaceuticals (AVIR) P/E (2020 - 2026)
Atea Pharmaceuticals (AVIR) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM Atea Pharmaceuticals (AVIR) P/E is -2.28. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Atea Pharmaceuticals (AVIR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.28 | +25.74% |
| 2025 | -1.81 | +7.91% |
| 2024 | -1.68 | -13.39% |
| 2023 | -1.94 | -117.36% |
| 2022 | 11.16 | +82.30% |
| 2021 | 6.12 | -96.33% |
| 2020 | 166.71 | N/A |
Comparison Atea Pharmaceuticals (AVIR) P/E with competitors
Atea Pharmaceuticals (AVIR) P/E is -2.28.